Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # FDA Approval
  • # DNA
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Research: Discovery of a new class of antimicrobials in soil bacteria

20 April 2024

Omalizumab – A study on kids reveals that the drug can limit dangerous reactions to allergy-triggering foods

28 February 2024

New antibody therapy to neutralize a wide variety of HIV-1 strains

19 July 2024

Highly mutated COVID-19 strain found in new countries

25 August 2023

Eli Lilly Responds to EMA’s Donanemab Marketing Authorization Rejection

29 March 2025

New therapy to prevent Antibody-Mediated-Rejection (AMR) of kidney transplant

31 May 2024

Patients with a rare inherited eye disease shows improvement after Gene Therapy Trials

9 September 2024

Eli Lilly’s Orforglipron, an Investigational Oral GLP-1 Weight-loss and Diabetes Pill Shows Similar Efficacy Results of Their Injectable GLP-1

18 April 2025

The Two Proteins Involved in Alzheimer’s Disease Have Distinct Effects on Brain Circuitry

7 February 2025

Sanger Sequencing Steps and Process

16 October 2024

Researchers discovered a suite of genes that influence the human head shape

18 November 2023

Intriguing New Class of Antimalarial Drugs Discovered

21 February 2025

GLP-1 Receptor

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist
Business Clinical Investigation Healthcare & Pharmaceuticals News

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist

Ajmal Aseem 14 April 2025

Data from the danuglipron clinical development program will be presented at a scientific meeting or published in a peer-reviewed journal in the future.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy